CT differentiation of poorly-differentiated gastric neuroendocrine tumours from well-differentiated neuroendocrine tumours and gastric adenocarcinomas

被引:26
|
作者
Kim, Seong Ho [1 ,2 ]
Kim, Se Hyung [1 ,2 ]
Kim, Min-A [3 ]
Shin, Cheong-il [1 ,2 ]
Han, Joon Koo [1 ,2 ]
Choi, Byung Ihn [1 ,2 ]
机构
[1] Seoul Natl Univ Hosp, Dept Radiol, 101 Daehangno, Seoul 110744, South Korea
[2] Seoul Natl Univ Hosp, Inst Radiat Med, Seoul 110744, South Korea
[3] Seoul Natl Univ Hosp, Dept Pathol, Seoul 110744, South Korea
基金
新加坡国家研究基金会;
关键词
Stomach; Neuroendocrine tumour; Adenocarcinoma; Metastasis; Computed tomography; ENDOCRINE TUMORS; CARCINOID-TUMORS; PATHOGENESIS; METASTASES; DISTENSION; CELL;
D O I
10.1007/s00330-015-3600-z
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
To evaluate the differential CT features of gastric poorly-differentiated neuroendocrine tumours (PD-NETs) from well-differentiated NETs (WD-NETs) and gastric adenocarcinomas (ADCs) and to suggest differential features of hepatic metastases from gastric NETs and ADCs. Our study population was comprised of 36 patients with gastric NETs (18 WD-NETs, 18 PD-NETs) and 38 patients with gastric ADCs who served as our control group. Multiple CT features were assessed to identify significant differential CT findings of PD-NETs from WD-NETs and ADCs. In addition, CT features of hepatic metastases including the metastasis-to-liver ratio were analyzed to differentiate metastatic NETs from ADCs. The presence of metastatic lymph nodes was the sole differentiator of PD-NETs from WD-NETs (P = .001, odds ratio = 56.67), while the presence of intact overlying mucosa with mucosal tenting was the sole significant CT feature differentiating PD-NETs from ADCs (P = .047, odds ratio = 15.3) For hepatic metastases, metastases from NETs were more hyper-attenuated than those from ADCs. The presence of metastatic LNs and intact overlying mucosa with mucosal tenting are useful CT discriminators of PD-NETs from WD-NETs and ADCs, respectively. In addition, a higher metastasis-to-liver ratio may help differentiate hepatic metastases of gastric NETs from those of gastric ADCs with high accuracy. aEuro cent Presence of metastatic LNs is a useful differentiator of PD-NETs from WD-NETs. aEuro cent Intact overlying mucosa with mucosal tenting suggests PD-NETs more than gastric ADCs. aEuro cent Metastatic LNs are larger in size and greater in necrotic volume in PD-NETs. aEuro cent Hepatic metastases from gastric NETs are more hyper-attenuated than those from ADCs.
引用
收藏
页码:1946 / 1957
页数:12
相关论文
共 50 条
  • [41] Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors
    Reidy, Diane L.
    Tang, Laura H.
    Saltz, Leonard B.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2009, 6 (03): : 143 - 152
  • [42] Review article: the investigation and management of gastric neuroendocrine tumours
    Basuroy, R.
    Srirajaskanthan, R.
    Prachalias, A.
    Quaglia, A.
    Ramage, J. K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) : 1071 - 1084
  • [43] Visceral Obesity and Metabolic Syndrome Are Associated with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors
    Santos, Ana P.
    Santos, Ana C.
    Castro, Clara
    Raposo, Luis
    Pereira, Sofia S.
    Torres, Isabel
    Henrique, Rui
    Cardoso, Helena
    Monteiro, Mariana P.
    CANCERS, 2018, 10 (09)
  • [44] Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets
    Park, Ha Young
    Kwon, Mi Jung
    Kang, Ho Suk
    Kim, Yun Joong
    Kim, Nan Young
    Kim, Min Jeong
    Min, Kyueng-Whan
    Choi, Kyung Chan
    Nam, Eun Sook
    Cho, Seong Jin
    Park, Hye-Rim
    Min, Soo Kee
    Seo, Jinwon
    Choe, Ji-Young
    Lee, Hye Kyung
    HUMAN PATHOLOGY, 2019, 87 : 83 - 94
  • [45] Giant gastric lipoma mimicking well-differentiated liposarcoma
    Hamdane, Mohamed Moncef
    Ben Brahim, Ehsen
    Salah, Meriam Belhaj
    Haouas, Nooman
    Bouhafa, Ahmed
    Chedly-Debbiche, Achraf
    PAN AFRICAN MEDICAL JOURNAL, 2012, 13
  • [46] Defining prognostic parameters of well-differentiated gastric neuroendocrine tumors based on metastatic potential: a two-center experience
    Kurtulan, O.
    Turhan, N.
    Gedikoglu, G.
    Akyol, A.
    Sokmensuer, C.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2022, 85 (02) : 339 - 345
  • [47] Histidine decarboxylase and urinary methylimidazoleacetic acid in gastric neuroendocrine cells and tumours
    Tsolakis, Apostolos V.
    Grimelius, Lars
    Granerus, Goran
    Stridsberg, Mats
    Falkmer, Sture E.
    Janson, Eva T.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (47) : 13240 - 13249
  • [48] Primary metastatic well-differentiated neuroendocrine tumor arising in a tailgut cyst
    Woehlke, M.
    Sauer, J.
    Dommisch, K.
    Goerling, S.
    Valdix, A.
    Hinze, R.
    PATHOLOGE, 2011, 32 (02): : 165 - 167
  • [49] Genomic characterization of a well-differentiated grade 3 pancreatic neuroendocrine tumor
    Williamson, Laura M.
    Steel, Michael
    Grewal, Jasleen K.
    Thibodeau, My Lihn
    Zhao, Eric Y.
    Loree, Jonathan M.
    Yang, Kevin C.
    Gorski, Sharon M.
    Mungall, Andrew J.
    Mungall, Karen L.
    Moore, Richard A.
    Marra, Marco A.
    Laskin, Janessa
    Renouf, Daniel J.
    Schaeffer, David F.
    Jones, Steven J. M.
    COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2019, 5 (03):
  • [50] PDGFRα expression as a novel therapeutic marker in well-differentiated neuroendocrine tumors
    Cavalcanti, Elisabetta
    Ignazzi, Antonia
    De Michele, Francesco
    Caruso, Maria Lucia
    CANCER BIOLOGY & THERAPY, 2019, 20 (04) : 423 - 430